Serum immunoglobulin fused interferon-α inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells

Interferon (IFN) has therapeutic potential for a wide range of infectious and proliferative disorders. However, the half-life of IFN is too short to have a stable therapeutic effect. To overcome this problem, serum immunoglobulin has been fused to IFN. In this study, the efficacy of serum immunoglob...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun-Sung, Yu, Kyeong Nam, Noh, Mi Suk, Woo, Min-Ah, Park, Sung-Jin, Park, Jin Hong, Hua, Jin, Cho, Hyun Sun, Hwang, Soon Kyung, Lee, Eun-Sun, Chung, Youn-Sun, Choi, In-Young, Kwon, Se-Chang, Cho, Myung-Haing
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839112/
https://www.ncbi.nlm.nih.gov/pubmed/18296888
http://dx.doi.org/10.4142/jvs.2008.9.1.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839112/
https://www.ncbi.nlm.nih.gov/pubmed/18296888
http://dx.doi.org/10.4142/jvs.2008.9.1.45

Ejemplares similares